InvestorsHub Logo
Followers 32
Posts 4433
Boards Moderated 0
Alias Born 05/16/2007

Re: None

Friday, 11/14/2008 1:10:46 PM

Friday, November 14, 2008 1:10:46 PM

Post# of 172
"We are delighted to be recognized once again in the Top 10 by the selection committee assembled by Windhover," said Dr. William P. Peters, Chairman and CEO of Adherex. "STS, currently in Phase 3 clinical trials worldwide, is the first compound in late-stage development attempting to reduce or prevent the significant hearing damage often seen with platinum-based chemotherapies such as cisplatin, a significant unmet need in both children and adults."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent FENC News